0001140361-18-014120.txt : 20180319 0001140361-18-014120.hdr.sgml : 20180319 20180319184220 ACCESSION NUMBER: 0001140361-18-014120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180316 FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewicki John A. CENTRAL INDEX KEY: 0001553352 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 18700187 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2018-03-16 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001553352 Lewicki John A. C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 President & CEO Stock Option (Right to Buy) 2.98 2018-03-16 4 A 0 125000 0.00 A 2028-03-15 Common Stock 125000 125000 D The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of March 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/ Alicia J. Hager, Attorney-in-Fact for John A. Lewicki 2018-03-19